Tim Roth lost his son, Cormac Roth, in 2022. Despite the heartbreak, Tim still played a role that would bring up those tragic ...

Scientists have developed cyanine-carborane salts, a new light-sensitive chemical that can precisely target and destroy aggressive cancer cells with fewer side effects. In mice, this therapy ...

H. Ma and S. Srivastava are joint first authors of this article. R. Sundar and P. Tan are joint corresponding and senior authors of this article.

The US Food and Drug Administration has approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC) to treat adult patients with symptomatic tenosynovial giant cell tumors (TGCT) who will not ...

Researchers develop targeted polymersomes to enhance methotrexate delivery, offering a promising new approach for treating aggressive choriocarcinoma ... into tumor cells, these novel polymersomes ...

A team led by Olena Taratula, a nanomedicine researcher at Oregon State University, has developed a method to improve drug targeting, ensuring the treatment reaches tumor cells while minimizing damage ...